跳至主要内容
临床试验/NCT05155449
NCT05155449已完成不适用

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effect of Probiotics on Gut Function in Healthy Chinese Adults

Probi AB1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年2月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Probi AB
入组人数
200
试验地点
1
主要终点
Bowel movements

研究概览

简要总结

The effect of probiotics on gut function in healthy subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 and 65 years
  • BMI between 18.5 and 27.9 kg/m²
  • Subjects having ≥ 3 bowel movements per day
  • Subject not satisfied with their bowel habits
  • Subject having frequent stools during more than 4 weeks
  • For women: Non menopausal with the same reliable contraception since at least 3 cycles before the beginning of the study and agreeing to keep it during the entire duration of the study
  • Subjects agreeing to keep their dietary and life habits unchanged throughout the study
  • Good general and mental health within the opinion of the investigator
  • Able and willing to participate to the study by complying with the protocol procedures as evidenced by a dated and signed ICF

排除标准

  • Suffering IBS according to Rome IV criteria, chronic intestinal disease, immunodeficiency disorder or immunosuppressive treatment
  • Clinically significant frequent constipation or diarrhea at the screening visit as judged by the Investigator
  • Suffering from a severe chronic disease or GI disorders found to be inconsistent with the conduct of the study by the investigator
  • Intake of antibiotics within 8 weeks prior to the start of the study
  • With regular intake of probiotics within four weeks prior to V1 visit
  • Under treatment or dietary supplement which could significantly affect parameter(s) followed during the study according to the investigator or stopped in a too short period before the V1 visit
  • Suspected alcohol or substance abuse
  • Use of medications other than contraceptives or prescribed medication after consulting with the investigator
  • History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk if participating in the study, or influence the results or the subject´s ability to participate in the study
  • With a known gluten intolerance, milk protein allergy
  • With a known or suspected food allergy or intolerance or hypersensitivity to any of the study products' ingredients
  • Pregnant or lactating women or intending to become pregnant within 3 months ahead
  • With significant change in food habits or in physical activity in the 3 months before the V1 visit
  • With a personal history of anorexia nervosa, bulimia or significant eating disorders according to the investigator
  • Having a lifestyle deemed incompatible with the study according to the investigator
  • Currently participating in another clinical study, has done so in the past 30 days or being in the exclusion period of a previous clinical trial
  • Under legal protection (guardianship, wardship) or deprived from his/her rights following administrative or judicial decision
  • Presenting a psychological or linguistic incapability to sign the informed consent or Investigator considers the subject unlikely to comply with study procedures, restrictions and requirements
  • Impossible to contact in case of emergency

结局指标

主要结局

Bowel movements

时间窗: 8 weeks

Reduction of the number of bowel movements

次要结局

未报告次要终点

研究者

发起方
Probi AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验